Targeted axillary dissection (TAD) is an advanced and increasingly important technique used in patients who receive neoadjuvant (pre-surgery) systemic therapy and who had biopsy-proven axillary lymph node involvement at the time of diagnosis.

In patients with node-positive disease at diagnosis, the standard historical approach was to proceed to full axillary dissection at the time of surgery regardless of how well the nodes responded to neoadjuvant treatment. This meant that patients whose axillary disease had completely responded to neoadjuvant chemotherapy — and who had no residual cancer in the axilla — still underwent the morbidity of a full axillary dissection that provided no therapeutic benefit.

TAD changes this by combining sentinel lymph node biopsy with the selective removal of the specific lymph node that was biopsy-proven positive at diagnosis and marked with a clip. This allows the surgeon to accurately assess the pathological response in the axilla — both in the marked node and the sentinel nodes — and to determine whether the nodal disease has been completely eradicated by neoadjuvant treatment.

How Targeted Axillary Dissection Works

At the time of the initial diagnostic biopsy of an involved axillary lymph node, a small titanium clip is placed in the biopsied node to mark it permanently. This is a simple addition to the standard biopsy procedure and takes only a few extra moments.

The patient then proceeds with neoadjuvant chemotherapy or targeted therapy. At the time of surgery, the clipped node is identified and removed alongside the sentinel nodes using a combination of techniques. The radiotracer used for sentinel node identification can be injected adjacent to the clipped node (or the clip can be localised separately using the same ROLL technique used for breast tumour localisation), allowing the gamma probe to locate and guide removal of the marked node along with the sentinel nodes.

Our team has contributed to published research on ROLL and related techniques used to identify the clipped node during TAD, reflecting our commitment to advancing surgical precision in axillary management.

What TAD Achieves

When the sentinel nodes and the marked node are all clear of cancer (a complete pathological response in the axilla), full axillary dissection can be safely omitted. The evidence supporting this approach comes from multiple clinical trials demonstrating that patients who achieve a complete axillary pathological response to neoadjuvant treatment do not benefit from completion axillary dissection and can be spared its associated morbidity.

When residual cancer is found in the marked node or sentinel nodes, axillary dissection is still recommended, as the pathological findings indicate that the axillary disease has not been fully eradicated by neoadjuvant treatment.

TAD therefore allows a highly personalised approach to axillary management after neoadjuvant therapy — escalating to full dissection for those who need it, while de-escalating safely in those who have achieved a complete response and can be spared the additional surgery.

Recovery After Lymph Node Surgery

Recovery from the lymph node surgery component of your breast cancer operation depends on the procedure performed.

After sentinel node biopsy alone, recovery is straightforward. The small axillary incision heals quickly, with bruising and tenderness expected for one to two weeks. Gentle arm and shoulder exercises should begin promptly under physiotherapy guidance to prevent stiffness. Most patients regain full shoulder mobility within two to four weeks.

After axillary dissection, recovery is more involved. One or two drains are managed at home for five to ten days. Shoulder stiffness is common and physiotherapy exercises are essential from the early post-operative period. Full shoulder mobility is usually restored within four to eight weeks with appropriate physiotherapy. Patients should be aware of the signs of lymphoedema and report any arm swelling, tightness, or heaviness promptly. Early assessment and treatment by a lymphoedema physiotherapist produces the best long-term outcomes.

After targeted axillary dissection, recovery is similar to sentinel node biopsy if the axilla was clear, or similar to axillary dissection if completion clearance was required.

Lymph Node Surgery at Breast & Surgical Oncology at The Poche Centre

Our surgeons perform the full spectrum of axillary lymph node surgery, with particular expertise in the more advanced techniques of targeted axillary dissection and coordination with microsurgical colleagues for prophylactic lymphovenous anastomosis. Our published research on axillary management reflects our ongoing engagement with the clinical evidence driving the field toward more accurate, less morbid, and more personalised axillary treatment.

Every axillary management decision is made by the full multidisciplinary team and discussed transparently with you before surgery. If you have questions about your axillary management as part of your breast cancer treatment, please raise them at your consultation.